Previous 10 | Next 10 |
Gainers: Biofrontera (NASDAQ:BFRI) +109%, Longeveron (NASDAQ:LGVN) +87%, Ocuphire Pharma (NASDAQ:OCUP) +41%, Better Therapeutics (NASDAQ:BTTX) +24%, Reviva Pharmaceuticals (NASDAQ:RVPH) +12%. Losers: Vallon Pharmaceuticals (NASDAQ:VLON) -34%, Pasithea Therap...
Pasithea Therapeutics (NASDAQ:KTTA) has entered into securities purchase agreements with certain institutional investors to purchase 8.68M shares of its common stock and warrants to purchase equal number of shares, at $3.50/share and warrant in a private placement priced at a premium to the m...
MIAMI BEACH, Fla., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA; KTTAW) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological di...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We’re starting the last day of this short holiday week with a dive into the biggest pre-market stock movers for Wednesday! Source: ventdusud / Shutterstock.com News moving shares today...
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Pasithea Therapeutics Corp. Surges Upon SPRAVATO Approval ” Pasithea Therapeutics Corp. (NASDAQ: KTTA) surged over 196% in premarket trading af...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Dick’s Sporting Goods (NYSE: DKS ) stock isn’t doing so hot on Tuesday following the release of its earnings report for the third quarter of 2021. Source: Jonathan Weiss / Shutterstock.com Let...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Petros Pharmaceuticals (NASDAQ: PTPI ) stock is surging higher on Tuesday following a filing with the U.S. Securities and Exchange Commission (SEC). Source: Shutterstock Let’s dive into that news below...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Dollar Tree (NASDAQ: DLTR ) stock is heading higher Tuesday after the company saw positive results from its price increase tests. Source: digitalreflections / Shutterstock.com Dollar Tree has been toying aroun...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pasithea Therapeutics (NASDAQ: KTTA ) stock is rocketing higher on Tuesday after adding esketamine nasal spray to its U.K. offerings. Source: Bukhta Yurii / Shutterstock.com The company is offering the esketa...
Gainers: Pasithea Therapeutics (NASDAQ:KTTA) +257%, Petros Pharmaceuticals (NASDAQ:PTPI) +73%, Gracell Biotechnologies (NASDAQ:GRCL) +64%, iSpecimen (NASDAQ:ISPC) +43%, Qualigen Therapeutics (NASDAQ:QLGN) +33%. Losers: Longeveron (NASDAQ:LGVN) -36%...
News, Short Squeeze, Breakout and More Instantly...
Pasithea Therapeutics Corp. Company Name:
KTTA Stock Symbol:
NASDAQ Market:
Pasithea Therapeutics Corp. Website:
MIAMI, June 13, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis typ...
-- PAS-004 inhibition of in vitro NRAS cell lines does not plateau in contrast to approved MEK inhibitors -- -- PAS-004 inhibition of in vitro NRAS cell lines is greater than selumetinib and binimetinib and similar to trametinib -- -- PAS-004 shows superior activity versus selumetinib and...